These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 28100566)

  • 1. Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions.
    Picco G; Petti C; Centonze A; Torchiaro E; Crisafulli G; Novara L; Acquaviva A; Bardelli A; Medico E
    EMBO Mol Med; 2017 Mar; 9(3):293-303. PubMed ID: 28100566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive characterization of RSPO fusions in colorectal traditional serrated adenomas.
    Sekine S; Ogawa R; Hashimoto T; Motohiro K; Yoshida H; Taniguchi H; Saito Y; Yasuhiro O; Ochiai A; Hiraoka N
    Histopathology; 2017 Oct; 71(4):601-609. PubMed ID: 28543708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis.
    Hilkens J; Timmer NC; Boer M; Ikink GJ; Schewe M; Sacchetti A; Koppens MAJ; Song JY; Bakker ERM
    Gut; 2017 Jun; 66(6):1095-1105. PubMed ID: 27511199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent PTPRK-RSPO3 fusions and RNF43 mutations in colorectal traditional serrated adenoma.
    Sekine S; Yamashita S; Tanabe T; Hashimoto T; Yoshida H; Taniguchi H; Kojima M; Shinmura K; Saito Y; Hiraoka N; Ushijima T; Ochiai A
    J Pathol; 2016 Jun; 239(2):133-8. PubMed ID: 26924569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R-Spondin chromosome rearrangements drive Wnt-dependent tumour initiation and maintenance in the intestine.
    Han T; Schatoff EM; Murphy C; Zafra MP; Wilkinson JE; Elemento O; Dow LE
    Nat Commun; 2017 Jul; 8():15945. PubMed ID: 28695896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RSPO3 antagonism inhibits growth and tumorigenicity in colorectal tumors harboring common Wnt pathway mutations.
    Fischer MM; Yeung VP; Cattaruzza F; Hussein R; Yen WC; Murriel C; Evans JW; O'Young G; Brunner AL; Wang M; Cain J; Cancilla B; Kapoun A; Hoey T
    Sci Rep; 2017 Nov; 7(1):15270. PubMed ID: 29127379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974.
    Liu J; Pan S; Hsieh MH; Ng N; Sun F; Wang T; Kasibhatla S; Schuller AG; Li AG; Cheng D; Li J; Tompkins C; Pferdekamper A; Steffy A; Cheng J; Kowal C; Phung V; Guo G; Wang Y; Graham MP; Flynn S; Brenner JC; Li C; Villarroel MC; Schultz PG; Wu X; McNamara P; Sellers WR; Petruzzelli L; Boral AL; Seidel HM; McLaughlin ME; Che J; Carey TE; Vanasse G; Harris JL
    Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20224-9. PubMed ID: 24277854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma.
    Li J; Wu G; Xu Y; Li J; Ruan N; Chen Y; Zhang Q; Xia Q
    Biomed Res Int; 2020; 2020():2527643. PubMed ID: 32104684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of antitumor effects of aspirin and LGK974 drugs on cellular signaling pathways, cell cycle and apoptosis in colorectal cancer cell lines compared to oxaliplatin drug.
    Bagheri M; Tabatabae Far MA; Mirzaei H; Ghasemi F
    Fundam Clin Pharmacol; 2020 Feb; 34(1):51-64. PubMed ID: 31233627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porcupine inhibitor LGK‑974 inhibits Wnt/β‑catenin signaling and modifies tumor‑associated macrophages resulting in inhibition of the malignant behaviors of non‑small cell lung cancer cells.
    Tang Y; Jiang M; Chen A; Qu W; Han X; Zuo J; Xu G; Song Y; Chen C; Ke X
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34080032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells.
    Kahlert UD; Suwala AK; Koch K; Natsumeda M; Orr BA; Hayashi M; Maciaczyk J; Eberhart CG
    J Neuropathol Exp Neurol; 2015 Sep; 74(9):889-900. PubMed ID: 26222502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RSPO fusion transcripts in colorectal cancer in Japanese population.
    Shinmura K; Kahyo T; Kato H; Igarashi H; Matsuura S; Nakamura S; Kurachi K; Nakamura T; Ogawa H; Funai K; Tanahashi M; Niwa H; Sugimura H
    Mol Biol Rep; 2014 Aug; 41(8):5375-84. PubMed ID: 24847761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RSPO3 promotes the aggressiveness of bladder cancer via Wnt/β-catenin and Hedgehog signaling pathways.
    Chen Z; Zhou L; Chen L; Xiong M; Kazobinka G; Pang Z; Hou T
    Carcinogenesis; 2019 Apr; 40(2):360-369. PubMed ID: 30329043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial RSPO3 Controls Vascular Stability and Pruning through Non-canonical WNT/Ca(2+)/NFAT Signaling.
    Scholz B; Korn C; Wojtarowicz J; Mogler C; Augustin I; Boutros M; Niehrs C; Augustin HG
    Dev Cell; 2016 Jan; 36(1):79-93. PubMed ID: 26766444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LPS-induced inflammatory response is suppressed by Wnt inhibitors, Dickkopf-1 and LGK974.
    Jang J; Jung Y; Kim Y; Jho EH; Yoon Y
    Sci Rep; 2017 Jan; 7():41612. PubMed ID: 28128299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway.
    Shah K; Panchal S; Patel B
    Pharmacol Res; 2021 May; 167():105532. PubMed ID: 33677106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant RSPO3-LGR4 signaling in Keap1-deficient lung adenocarcinomas promotes tumor aggressiveness.
    Gong X; Yi J; Carmon KS; Crumbley CA; Xiong W; Thomas A; Fan X; Guo S; An Z; Chang JT; Liu QJ
    Oncogene; 2015 Sep; 34(36):4692-701. PubMed ID: 25531322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R-spondin-3 promotes proliferation and invasion of breast cancer cells independently of Wnt signaling.
    Ter Steege EJ; Doornbos LW; Haughton PD; van Diest PJ; Hilkens J; Derksen PWB; Bakker ERM
    Cancer Lett; 2023 Aug; 568():216301. PubMed ID: 37406727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor.
    Tzeng HE; Yang L; Chen K; Wang Y; Liu YR; Pan SL; Gaur S; Hu S; Yen Y
    Oncotarget; 2015 May; 6(13):11061-73. PubMed ID: 25857298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer.
    Hashimoto T; Takayanagi D; Yonemaru J; Naka T; Nagashima K; Yatabe Y; Shida D; Hamamoto R; Kleeman SO; Leedham SJ; Maughan T; Takashima A; Shiraishi K; Sekine S
    Br J Cancer; 2022 Oct; 127(6):1043-1050. PubMed ID: 35715628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.